StockWatch
·
Pharmaceuticals
Quarterly Result4 Nov 2026, 01:37 pm

Marksans Pharma Declares Unaudited Q2 FY27 Financial Results

AI Summary

Marksans Pharma Ltd announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results at a meeting held on November 04, 2026. The company's statutory auditors, MSKA & Associates LLP, have submitted their Limited Review Reports with an unmodified opinion.

Key Highlights

  • Unaudited financial results for Q2 FY27 declared.
  • Both standalone and consolidated results were approved.
  • Board meeting held on November 04, 2026.
  • Auditors issued an unmodified opinion.
  • Results available on the company website.